Bonte F, Rudolphus A, Tan K Y, Aerts J G
Sint Franciscus Gasthuis, afd. Longziekten, Kleiweg 500, 3045 PM Rotterdam.
Ned Tijdschr Geneeskd. 2003 Jun 14;147(24):1185-8.
Five patients became short of breath following the use of a waterproofing spray in an unventilated room: one 40-year-old woman and 4 men aged 40, 18, 21 and 39 years, respectively. After treatment the complaints diminished within the course of a few weeks. Waterproofing sprays are commonly used to make clothing and shoes water-repellent. Several hours after inhalation of such sprays symptoms of dyspnoea can occur. Without therapy this can lead to pulmonary fibrosis. Corticosteroid therapy seems to shorten the duration of complaints in the acute phase and preclude fibrosis. It is therefore advisable to present patients with respiratory complaints following inhalation of waterproofing sprays at an emergency department. A chest X-ray and blood gas analysis should be performed. In case of abnormalities, patients should be hospitalised.
一名40岁女性和四名男性，年龄分别为40岁、18岁、21岁和39岁。经过治疗，这些症状在几周内减轻。防水喷雾通常用于使衣物和鞋子具有防水性能。吸入此类喷雾数小时后可能会出现呼吸困难症状。未经治疗，这可能会导致肺纤维化。皮质类固醇疗法似乎可以缩短急性期症状的持续时间并预防纤维化。因此，建议在急诊科对吸入防水喷雾后出现呼吸道症状的患者进行诊治。应进行胸部X光检查和血气分析。如有异常，患者应住院治疗。
